Publication | Closed Access
Melatonin in patients with cancer receiving chemotherapy: a randomized, double-blind, placebo-controlled trial.
79
Citations
0
References
2014
Year
Melatonin in combination with chemotherapy did not affect survival and adverse events of advanced patients with NSCLC, but there was a trend for better HRQoL.